Related by context. All words. (Click for frequent words.) 68 Initiates Clinical Trial 68 Migraine Drug 68 Submits NDA 68 Drug Fails 68 Completes Patient Enrollment 67 Gets FDA Clearance 67 Licenses Novel 67 Initiates Clinical 67 Extends Collaboration 67 Receives Milestone Payment 67 Announce Collaboration Agreement 67 Lupus Drug 66 Receives Approvable Letter 66 Clinical Trial Data 66 Initiates Phase III 66 Arthritis Drug 66 Oncology Compounds 66 Presents Positive 66 Osteoporosis Drug 66 Receive Milestone Payment 66 FDA Approvals 66 Initiates Enrollment 65 BioSante Pharmaceuticals Announces 65 Present Preclinical Data 65 Inc Therapeutic Competitors 65 Psoriasis Drug 65 Investigational Compound 65 Begins Clinical Trial 65 Milestone Payment 65 IG HCR ;) CO 64 Submits Biologics License Application 64 Rheumatoid Arthritis Drug 64 Enrolls First 64 Therapeutic Competitors Companies 64 Initiates Dosing 64 Begins Dosing 64 Announces Discontinuation 64 Milestone Payments 64 Completes Dosing 64 Momenta Pharmaceuticals MNTA 64 Demonstrates Significant 64 Presents Preclinical 64 Schizophrenia Drug 64 Therapeutic Competitors companiesandmarkets.com adEgemonye 64 Files IND 64 FDA Clears 64 Demonstrates Positive 63 Initiates Clinical Trials 63 Licenses Patents 63 FDA Okays 63 Meets Primary Endpoint 63 Initiates Phase II 63 Receives Orphan Drug Designation 63 Drug Shows Promise 63 NPS Pharma 63 Announce License Agreement 63 Lung Cancer Drug 63 Announces FDA Clearance 62 Small Molecule Drug 62 Submits Response 62 Successfully Completes Phase 62 Announces Poster Presentations 62 Presents Preclinical Data 62 Completes Enrollment 62 Develop Novel 62 AM Vitals 62 Receives Tentative Approval 62 Sanofi NYSE SNY 62 Weight Loss Drug 62 Restructures Operations 62 Partnering Agreements 62 HCV Protease Inhibitor 62 Collaborators Publish 62 FDA Accepts 62 PharmaVitae Profile 62 Milestone Payment From 61 Pharmacueticals 61 Reveals Positive 61 Biomarker Study 61 Presents Positive Preclinical 61 Sign Licensing Agreement 61 Generic Versions 61 Reports Preclinical Data 61 Amends Agreement 61 Identifies Potential 61 Therapeutic Competitors 61 Demonstrates Sustained 61 MEMY 61 Clinical Outcome 61 Receives Complete Response 61 Begins Shipment 61 Granted Orphan Drug 61 Submits Application 61 Submits IND 61 NOVN 61 Study Shows Significant 61 Isis Pharma 61 Integra Lifesciences 61 Xoma Ltd 60 Receives Orphan Drug 60 Announce Licensing Agreement 60 Initiate Clinical Trial 60 Penwest Pharma 60 Transdermal Patch 60 Abstract Accepted 60 BIOTECH STOCKS 60 Awarded Patents 60 Ltd Therapeutic Competitors 60 PHRM 60 Announces Tentative Approval 60 Initiates Phase 2b 60 Genes Involved 60 Inflammatory Diseases 60 Therapeutic Competitors Report 60 Enzon Pharmaceuticals Inc 60 Vaccine Adjuvant 60 Immunotherapeutic 60 Supernus Pharmaceuticals 60 Misses Expectations 60 Commercialize Novel 60 Drug Candidate 60 AUDIO PROVIDED BY 60 Demonstrates Ability 60 Beats Views 59 Anticancer Drug 59 Announces Presentation 59 Updates FY# EPS 59 Preclinical Study 59 Aegerion Pharmaceuticals Inc. 59 1Q Profit Dips 59 Small Molecule 59 Schizophrenia Treatment 59 RNAi Therapeutics 59 Backs FY# 59 Inc POZN 59 Alnylam ALNY 59 please visit http:/www.vandapharma.com 59 Genentech sanofi aventis 59 Idenix Novartis 59 * vwd PRN 59 Obtains License 59 Liquid Crystals 59 Namenda Memantine HCl 59 Tibotec BVBA 59 Anti Tumor 59 Sees Positive 59 Microwave Ablation System 59 Anticancer Agent 59 Receives Fast Track 59 Founding Scientist 59 KAI Pharmaceuticals 59 Achieves Primary Endpoint 59 Adverse Event 59 Carotid Artery Stenting 59 Investigational Treatment 59 Cubist Pharma 59 Metabolic Disease 59 Receives Positive Opinion 59 Shows Efficacy 59 Tops Views 58 PhD RPh 58 Sign License Agreement 58 Earnings Decline 58 Submits Supplemental 58 Shows Promise Against 58 Patients Treated With 58 Exceeds Estimates 58 Hepatic Encephalopathy 58 Beats Forecast 58 NASDAQ ONXX 58 Tops Expectations 58 Antisense Pharma GmbH 58 Xcytrin R 58 GILD GILD 58 Avanir Pharma 58 Amends Stockholder Rights 58 Teva Provides Update 58 VIVUS Announces 58 Preclinical Data 58 Drops Sharply 58 JAK Inhibitor 58 OTC BB PVCT 58 Awarded Qualifying Therapeutic 58 MLNM 58 TKPHF 58 NASDAQ PPDI 58 Nasdaq IPXL 58 Inflammatory Disease 58 ERYtech 58 Momenta Pharma 58 Reduces Mortality 58 QLTI 58 Multicenter Phase 58 Auxilium Pharma 58 OSI Pharma 58 NYSE WYE 58 Lifts FY# 58 Launches Generic Version 58 Athena Neurosciences 58 Anti Infectives 58 Demonstrates Potential 58 Receives Clearance 58 Quark Pharmaceuticals 57 CNS Disorders 57 Embolic Protection 57 Psivida 57 R lenalidomide 57 Ticks Higher 57 Prognostic Value 57 Metabolic Disorder 57 Nasdaq IDIX 57 Systemic Delivery 57 Adverse Reactions 57 Transdermal Delivery 57 Boosts Forecast 57 Impax Labs 57 Affirms FY# 57 EMD Biosciences Inc. 57 Laboratories Rahway NJ 57 Catalyst Biosciences 57 Underperforms 57 please visit http:/www.atherogenics.com 57 Liprotamase 57 Sees Steady 57 Beats Forecasts 57 Results Disappoint 57 Syntonix Pharmaceuticals 57 Nasdaq ACHN 57 NDQ 57 Nasdaq SCLN 57 Wellstat 57 AMEX KAL 57 Patent Covering 57 NASDAQ DIGE 57 Regains Full 57 JAK2 Inhibitor 57 Exploit collaboration 57 Kinase Inhibitor 57 Novartis Novo Nordisk 57 Randomized Study 57 Voluntarily Withdraws 57 EYET 57 Therapeutic Antibody 57 Aloxi ® 57 See CLINICAL PHARMACOLOGY 57 Lowers FY# EPS 57 Pegloticase 57 Novel Therapies 57 Announce Initiation 57 Takeda Pharma 57 visit http:/www.PAREXEL.com 57 Tumor Targeting 57 RGEN 57 markets HP Acthar 56 PFIZER INC. 56 PRN FDA Approves 56 Diastolic Heart Failure 56 Obtains CE Mark 56 LLY Short Term 56 Acquire Privately Held 56 Protein Expression 56 Novartis AG Schering Plough 56 Becton Dickinson BD 56 Profit Beats 56 Corp. ADLR 56 FDA Approves Generic 56 Cypher Sirolimus 56 Aspreva Pharmaceuticals Corporation 56 GlaxoSmithKline Plc Novartis AG 56 Biopharmaceutical Industry 56 SUTENT ® 56 CureDM 56 ILEX Oncology 56 Adventrx Pharmaceuticals 56 Earnings Disappoint 56 Profit Misses 56 Takeda Kyowa Hakko Kirin 56 visit http:/www.martek.com 56 Partnering Guide 56 Seattle Genetics SGEN 56 Novel Therapeutic 56 Tops Estimates 56 Corp. Nasdaq GENZ 56 segment Biotest 56 NASDAQ SCRX specialty 56 Inc CEPH 56 Inc AMGN AMGN 56 Multiple Ascending Dose 56 platform HDL Mimetic 56 ICOS Corporation 56 Febuxostat 56 Japanese Stocks Climb 56 Package Insert 56 Lower Than Expected 56 Idera Pharmaceuticals 56 Iloperidone 56 Regains Nasdaq 56 Chemotherapeutic Agents 56 Agios Pharmaceuticals 56 Upside Surprise 56 Idenix Pharmaceuticals 56 Biomarin 56 Tops Forecasts 56 Personalised Medicine 56 Vaccine Protects Against 56 Antipsychotic 56 Protein Biomarker 56 Amgen Bayer Schering 56 suitablility 56 blood thinner Xarelto 56 PARP Inhibitor 56 IVGN 56 Progenics Pharmaceuticals 56 DepoMed 56 Inc. www.micromet inc.com 56 Emphasys Medical 56 Exceed Estimates 56 Zosano Pharma 56 M.D. Joins 56 Nasdaq MDSO 56 TissueInformatics 55 Tops Consensus 55 Amylin Eli Lilly 55 Spinal Implant 55 Akebia Therapeutics 55 AstraZeneca PLC Bristol Myers 55 Improved Margins 55 R MSCRAMM 55 Fabry Disease 55 Raises Forecast 55 Regulatory Submissions 55 please visit http:/www.astrazeneca-us.com 55 Diabetic Neuropathy 55 WeissComm Partners +#-#-#-# 55 Antibody Discovery 55 Consensus Estimates 55 Pharmasset VRUS 55 Preclinical Development 55 Novel Inhibitor 55 Pharma Merck Serono 55 Fluconazole 55 Akzo Organon 55 proprietary intravenous formulation 55 PHARMACEUTICALS 55 Beats Estimates 55 PFE PFE 55 Futures Slip 55 CYTR 55 Diabetic Foot Ulcer 55 Genentech Wyeth Pharmaceuticals 55 Consolidation Continues 55 Ests 55 Hypercholesterolemia 55 Saegis Pharmaceuticals 55 Hydra Biosciences 55 Co BRM.BE holdings 55 Avian Influenza Vaccine 55 Vitrasert R 55 Investigational Drug 55 Danazol 55 Teva Pharma 55 Taligen Therapeutics 55 Oral Mucositis 55 Fibrin Patch 55 Stelios Papadopoulos Ph.D. 55 Onyx Pharma 55 Maven Semantic 55 Cima Labs 55 Matches Expectations 55 Smith Kline Beecham 55 Clinical Trial Enrollment 55 Boehringer Ingelheim Bristol Myers 55 Profit Edges Up 55 FDA Approves Expanded 55 Below Estimates 55 Pharmaceuticals Initiates 55 Acceleron Pharma 55 Corporation GENZ 55 epoetin zeta 55 Expects Higher 55 Co BMY 55 Salix Pharma 55 Suicidality 55 VNS Therapy TM 55 LEAD Therapeutics 55 Actelion Pharmaceuticals Ltd 55 Ionic Liquids 55 Metabolic Endocrinology 55 Cardiometabolic 55 BAYRY 55 BioPharmaceutical 55 Sandoz Novartis 55 Boehringer Ingelheim MedImmune 55 Anticancer Agents 55 Actelion Pharmaceuticals Ltd. 55 please visit www.astrazeneca.com 55 APPX 55 Xytis 55 Teva Pharm 55 Immune Therapy 55 Kiadis 55 SYN X 55 Beats Estimate 55 Benign Prostatic Hyperplasia 55 Merck OSI Pharmaceuticals 55 Arqule 55 COLAZAL R 55 Biogen Idec Elan 55 Orbimed Advisors LLC 55 Edges Higher 55 www.ucb.com 55 SPL# Gel vaginal microbicide 55 Astellas Pharmaceuticals 54 GENASIS 54 Drug Interactions 54 please visit http:/www.sunesis.com 54 Inc. Nasdaq MLNM 54 Cancer Biomarkers 54 Heart Transplant Recipients 54 GlaxoSmithKline MedImmune 54 lexidronam injection 54 Beats Expectations 54 Aegerion Pharmaceuticals 54 Aruvian R'search presents 54 Beat Expectations 54 Bristol Myers Squibb sanofi 54 Genentech GlaxoSmithKline 54 technology visit http:/www.genmab.com 54 acetonide FA 54 Remains Flat 54 Crofelemer budesonide foam 54 Genvec 54 Meets Expectations 54 Zeneus 54 Sees Higher 54 Amira Pharmaceuticals 54 Biogen Elan 54 Remains Visible 54 Methylphenidate Transdermal System 54 Market Awaits 54 Roland Haefeli 54 Astex Therapeutics 54 Bayhill Therapeutics 54 Inc. Nasdaq AGIX 54 Atypical Antipsychotics 54 Competitor Report 54 NASDAQ OMER 54 Absorbable 54 Ridaforolimus 54 Genentech Biogen Idec 54 Geodon ziprasidone 54 Tyrosine Kinase Inhibitor 54 AVEO Pharmaceuticals 54 Lowers FY# 54 Millenium Pharmaceuticals 54 Pharmaxis ASX PXS 54 Crucell NV NYSE Euronext 54 NASDAQ MYRX 54 Investors Await 54 Personalized Genetic 54 Civacir 54 Alder Biopharmaceuticals 54 Biotherapeutic 54 Downside Risk 54 visit www.FRX.com 54 Visit www.BASInc.com 54 Gene Silencing 54 Oxybutynin 54 CNS Therapeutics 54 FDA APPROVES 54 Corixa Corporation 54 Myriad Genetics Inc 54 Boehringer Ingelheim Pharma 54 Novartis Organon 54 Shows Modest 54 Cardiotoxicity 54 RapidMist 54 Therapeutic Proteins 54 Diagnostic Criteria 54 Islet Transplantation 54 Nasdaq CRXL 54 Less Than Estimated 54 Misses Consensus 54 Buying Opportunity 54 CPT Codes 54 Cubist Pharmaceuticals CBST 54 Misses Forecasts 54 Glatiramer Acetate 54 http:/www.sunesis.com 54 Desvenlafaxine 54 Dealmaking Profile 54 Co. MRK.N 54 NICE Recommends 54 Targeted Therapies 54 Outlook Brightens 54 s crizotinib ZAH 54 Safinamide 54 Ortho Cept 54 Atopic Dermatitis 54 Adentri 54 Nasdaq IMMU 54 Neuroanatomy 54 Nasdaq ANPI 54 Cephalon GlaxoSmithKline 54 Edges Down 54 Pazopanib 54 Biopharm 54 Immediately Accretive 54 Bristol Myers Squibbs 54 Pares Losses 53 Profit Tops Estimates 53 Therapeutic Antibodies 53 Announce Collaboration 53 Orally Active 53 Profits Surge 53 Luveris R Ovidrel R 53 Cancer Res 53 Analytical Tool 53 ZyStor Therapeutics Inc. 53 J.P. Morgan Healthcare 53 Quark Biotech 53 Sees Weak 53 Merck Serono Nycomed 53 Muraglitazar 53 Capoten 53 Ticks Up 53 Crystallographic 53 Cytokinetics CYTK 53 Potelligent Technology 53 Anti Infective 53 4Q Profit Tops 53 Nasdaq APPY 53 Fumapharm 53 Scripps Genomic Medicine 53 Nereus Pharmaceuticals 53 Alexza Pharma 53 markets COLAZAL 53 Interferon Alfa 53 please visit www.eisai.com 53 Profits Rise 53 Phase III Clinical Trials 53 Biogen IDEC 53 Bazedoxifene 53 Bucindolol 53 Parathyroid Hormone 53 Myers Squibb 53 Abbott Laboratories Amgen 53 Pharmacogenomic 53 Stronger Than Expected 53 Sustained Release 53 Beat Estimates 53 Provides Detailed 53 Nasdaq ONXX 53 Kinase Inhibitors 53 Diovan Exforge Tekturna Zelnorm 53 Protease Inhibitors 53 MedChem 53 pralatrexate injection folate analogue 53 Inc. Nasdaq AMGN 53 R Saizen R 53 Biomaterial 53 Risk Stratification 53 Astex Therapeutics Limited 53 Bioavailability 53 Posts Modest 53 Antibody Drug Conjugate 53 Dips Slightly 53 Antimicrobial Coating 53 Cheminformatics 53 PHARMACEUTICALS INC 53 Inc FRX 53 Thalomid ® 53 Misses Forecast 53 Medisorb ® 53 Preclinical Models 53 Company LLY LLY 53 ASX PGL 53 THALOMID R 53 Xenoport Inc 53 AstraZeneca Symbicort 53 ALN HPN 53 Boxed Warnings 53 Pandemic Flu Vaccine 53 Small Molecules 53 Aricept donepezil 53 HDL Selective Delipidation 53 Successfully Treats 53 Percutaneous Tibial Nerve Stimulation 53 Celgene Thalomid 53 License Pact 53 Partneringreview 53 Zoloft sertraline 53 Revised Upward 53 Squibb Eli Lilly 53 sanofi aventis Bayer Schering 53 SIX RO ROG 53 Organon Pharmaceuticals 53 #:#-# [006] 53 BRILINTA 53 Gene Expression Analysis 53 AstraZeneca AZN.L 行情 53 DEY LP 53 Lanthanum Carbonate 53 MOVIPREP R 53 NYSE PFE Exelon Rivastigmine 53 Wyeth Enbrel 53 J Cardiovasc 53 Affymax AFFY 53 Roche Boniva 53 AMEX AIS 53 Sirolimus eluting 53 HIV treatments Reyataz 53 Glaxosmithkline Plc 53 Ondansetron Orally Disintegrating Tablets 53 Stocks Seesaw 53 Ekes Out 53 PF # [002] 53 Pierre Fabre SA 53 Takeda Kyowa Hakko 53 Midday Trading 53 Leonhard Kurz 52 SOLVAY PHARMACEUTICALS 52 OTC BB EMIS 52 Cancer Vaccines 52 ALSO NOTED 52 estrogen receptor modulators 52 M.D. Ph.D. 52 Drugmakers AstraZeneca 52 Egrifta 52 NovoNordisk 52 Nasdaq CRME 52 Nearly Quadruples 52 Recombinant Human 52 Ascend Therapeutics 52 Commences Phase III 52 Zelos Therapeutics 52 Gedeon Richter Plc 52 www.bms.com 52 NV1FGF 52 Vertebral Fracture 52 visit www.targanta.com 52 HuMax TAC 52 Weaker Than Expected 52 Actonel risedronate 52 Trastuzumab DM1 52 Insulin Nasal Spray 52 Vildagliptin 52 proprietary radiolabeled monoclonal 52 Edges Lower 52 Falls Sharply 52 Sees Slower 52 Nucleic Acids 52 Reminyl galantamine 52 Technosphere ® 52 HDAC Inhibitor 52 Forest Labs FRX 52 Anti infective 52 Nasdaq MDCO 52 Trandolapril 52 Allergan AGN 52 Humira adalimumab 52 Chart Presentation 52 www.medimmune.com 52 serotonin norepinephrine reuptake inhibitor 52 Prospective Multicenter 52 Zorbtive TM 52 Stakeholder Opinions 52 Interferon Alpha 52 oral renin inhibitor 52 RECOTHROM R 52 Bioservices 52 Primary Endpoint 52 Myocet 52 Neurobiological 52 please visit www.abraxane.com 52 Specialty Diagnostics 52 Tibotec Virco 52 KYTHERA Biopharmaceuticals Inc. 52 midstage clinical 52 Stocks Little Changed 52 development DSC# novel 52 Cancidas 52 NRPH 52 Qiagen NASDAQ QGEN 52 Neurome 52 Aflibercept 52 Higher Than Expected 52 GERD migraine headaches 52 Zybrestat 52 developing Zerenex ferric 52 Lexapro Effexor Serzone 52 pain relievers Duragesic 52 Calcium Acetate 52 Orally Disintegrating 52 Depomed DEPO 52 Mylan Nasdaq MYL 52 Immunotherapies 52 Novel Therapeutics 52 Herceptin Rituxan 52 Weaker Yen 52 DepoCyt 52 MEDAREX 52 Up Sharply 52 glucokinase activator 52 M# rationally 52 Ereska 52 Curidium 52 Nucleoside 52 Gonal f R 52 pregabalin Lyrica 52 oncolytic virus therapies 52 Encysive Pharmaceuticals 52 http:/www.gsk.com/ 52 CAMPATH 52 Roopesh Patel 52 thalidomide Thalomid 52 External Defibrillators 52 Bristol Myers Squibb Pravachol 52 Stocks Recover 52 Product Monograph 52 Prolexys 52 Campath ® 52 Protein Therapeutics 52 CardioVascular BioTherapeutics 52 MEK Inhibitor 52 Prospective Randomized 52 Multaq dronedarone 52 ophthalmics 52 Seen Flat 52 ZARS Pharma 52 Exelixis EXEL 52 Nasdaq IDRA today 52 Stays Flat 52 Enhanze 52 Atelvia 52 MOGN 52 Intendis 52 ESTRASORB ® 52 Below Expectations 52 Remains Positive 52 Frozen Shoulder syndrome 52 Biogen Idec Tysabri 52 Shionogi Pharma 52 Awaits Approval 52 Copegus R 52 Fujisawa Healthcare Inc. 52 Profits Tumble 52 Nudges Up 52 miRagen Therapeutics 52 NeoGenesis 52 Anti CD# Antibody 52 Aciphex R 52 Detailed Product 52 Aptamer 52 Inches Higher 52 Nasdaq SHPGY 51 Sanofi Aventis Schering Plough 51 Losses Deepen 51 Gain Update3 51 Rise Less Than 51 IL# PE#QQR 51 Smaller Than Expected 51 Topiramate Tablets 51 Kepivance 51 Inflation Worries 51 TolerRx 51 Epoetin 51 Bayer Boehringer Ingelheim 51 Vascular Targeting Agents 51 please visit www.dsi.com 51 About BioCryst BioCryst 51 Pafuramidine 51 Spiriva inhaler 51 Seen Boosting 51 Slower Growth 51 Ascenta Therapeutics 51 Encysive surged 51 Degarelix 51 Christine Cassiano 51 Asthma COPD 51 Disease Modification 51 Inc SWOT Framework 51 Double Digit Earnings 51 Kosan dependence 51 Dry Powder Inhaler 51 visit www.genmab.com 51 Inch Higher 51 Alexion Soliris 51 Gonal f 51 VentiRx Pharmaceuticals 51 Vascular Graft 51 Sees Weaker 51 Corp. BVF CN 51 AstraZeneca Targacept 51 Oral Insulin 51 Neurotherapeutics 51 Sanvar 51 Mr. Pilnik 51 Licensing Agreements 51 Hematide ™ peginesatide 51 ABT.N Quote Profile Research 51 VIVUS Qnexa 51 Rebounds Slightly 51 MARKET COMMENT London 51 Forma Therapeutics 51 Immunoassay Systems 51 Ovitrelle R Serostim 51 Modest Gains 51 Antifungals 51 THALOMID 51 ENZON 51 SmPC 51 Oxcarbazepine 51 Wyeth Lederle 51 Tobira Therapeutics 51 Veregen 51 Stocks Wobble 51 Edges Up 51 INTERNATIONAL HOLDINGS INC. 51 AFREZZA TM 51 OTC RHHBY 51 Stocks Climb Higher 51 Holds Gains 51 ® lenalidomide 51 http:/www.cephalon.com/ 51 Hepatitis C Virus 51 Alza Corporation 51 KuDOS 51 Amlodipine Besylate 51 PULMICORT 51 Sentiment Improves 51 pharmacogenomics pharmacogenetics 51 Extends Losses 51 CYCLOSET ® 51 Pharmas 51 Epothilone 51 urology oncology 51 Motexafin Gadolinium 51 SmarTrend Diagnostic Substances 51 rxRNA 51 Sharply Higher 51 Dr. Sheares 51 Daptomycin 51 Postdoctoral Position 51 Berlex Biosciences 51 Aryplase 51 Impax Laboratories Inc 51 NV Organon 51 Productivity Rises 51 novel oral anticoagulant 51 Nasdaq PRXL 51 Vernalis plc 51 Nasdaq PARD biopharmaceutical 51 Fosamax alendronate sodium 51 Stocks Rise Modestly 51 Outlook Uncertain 51 Stocks Bounce Back 51 Dyslipidemia 51 Jobless Claims Increase 51 Drop Sharply 51 Cerenis Therapeutics 51 Activity Slows 51 etanercept Enbrel 51 Conjugate 51 Pathway Diagnostics 51 Bristol Myers Squibb Celgene 51 gets USFDA nod 51 aventis 51 Gemzar gemcitabine 51 Oxytrol R 51 BiDil XR 51 Hepatocellular Carcinoma 51 Novartis Sanofi Aventis 51 Saforis 51 Alair Bronchial Thermoplasty System 51 GenPath 51 Kissei Pharmaceutical 51 Heparins 51 Rises Less Than 51 Session Highs 51 Torisel temsirolimus 51 Steady Decline 51 SurModics SRDX 51 carbamazepine phenobarbital phenytoin rifampin 51 Orphan Diseases 51 severe hypercholesterolemia 51 R agalsidase beta 51 Myocardial Perfusion Imaging 51 Novartis AG Exelon 51 BioPartners 51 KLIBOR Futures Close 51 superparamagnetic iron oxide nanoparticles 51 Neuroprotective Effects 51 Diasome 51 GlaxoSmithKline Lamictal 51 Cethrin R 51 Biogenerics 51 Sanofi Aventi 51 www.gsk.com 51 Predictive Toxicology 51 Campto 51 Inc. NASDAQ AMGN 51 Rally Falters 51 Percent Jump 51 including eniluracil ADH 51 Gene Expression Profiling 51 Novartis Diagnostics 51 Dementia Related Psychosis 51 Strattera atomoxetine 51 Selects Cognos 51 Exceed Forecasts 51 Cefzil 51 Leflunomide 51 Curacyte 51 Allergan NYSE AGN 51 AMPLATZER R 51 Exceed Forecast 51 Stocks Dip 51 Surgical Sealant 51 Stronger Dollar 51 NASDAQ SOMX specialty 51 Ms. Lewent 51 Selenia Dimensions System 51 Traders Await 51 Better Than Expected 51 Mediphase Venture Partners 51 Growth Slowing 51 Yuan Revaluation 50 Avastin Herceptin 50 ONCONASE ranpirnase 50 Betaferon R 50 PLAVIX ® 50 Lexapro escitalopram 50 dutogliptin 50 Antiepileptic Drug 50 Sanofi Aventis Novartis 50 Avonex interferon beta 1a 50 successfully commercialize Iluvien 50 Forecast Update1 50 Copegus ® 50 equine osteoarthritis marketed 50 Waters WAT 50 Elagolix 50 TRANSDUR ® 50 please visit www.lexpharma.com 50 Seroquel quetiapine 50 LEVADEX ™ 50 MEVACOR 50 Crop BioScience 50 Erlotinib 50 Insulin Glargine 50 As Investors Await 50 Cautious Outlook 50 Veronate R 50 Clolar ® 50 IMPACS R 50 zoledronic acid Reclast 50 Traversa Therapeutics 50 Toyo Bio 50 Sanofi aventis NYSE SNY 50 Molecular Diagnostic 50 Toxicogenomics 50 Improved Second Quarter 50 Tenormin 50 Pharmacoeconomic 50 PAION AG ISIN 50 RELOVAIR ™ 50 Stocks Rise Moderately 50 Celldex Therapeutics CLDX 50 fluvastatin Lescol 50 Referenced EEG 50 Benicar HCT 50 Deforolimus 50 Locus Pharmaceuticals 50 Brovana 50 Stocks Rise Amid 50 Pharmacogenetic 50 companies visit www.tpna.com 50 FOLOTYN ® 50 visit www.genenews.com 50 mechanical thrombectomy 50 Nextech Venture 50 GlaxoSmithKline Sanofi Aventis 50 Merck MRK Pfizer PFE 50 ZEVALIN ® 50 sirtuin therapeutics 50 zoledronic acid Zometa 50 INFI 50 Theranostics 50 Aarkstore 50 molecular chaperone regulation 50 Ception Therapeutics 50 Survey Conducted 50 Vitrasert ® 50 Roger Longman 50 traditional pill Alesse 50 Stedesa 50 Stocks Sag 50 Metabolic Profiling